
Medartis Holding AG
MDRSF
Updated: 23/09/2026, 02:35:21
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries. Operating under its prominent APTUS and MODUS brands, Medartis provides a comprehensive array of osteosynthesis instruments. These specialized tools and implants are designed for a wide spectrum of anatomical applications, including procedures involving the hand, wrist, elbow, shoulder, foot, and ankle, alongside the mandible, midface, orthognathic, and cranial regions. Medartis serves a diverse international client base, including surgeons, hospitals, medical centers, and various group purchasing organizations.
No summaries found.
- Share price
- $115.00
- Market cap
- $1.43B
- Exchange
- OTC
- Currency
- USD
- CEO
- Matthias Schupp
- Employees
- 1,337
- IPO date
- 17/01/2020
- Beta
- 1.17
- Last dividend
- $0.00
- Day range
- $115.00 – $115.00
- 52-week range
- $66.68 – $115.00
- 1-day performance
- 0.00%
- 1-year performance
- 72.47%
- Current drawdown (1Y)
- 0.00%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- CH0386200239
- Created
- 07/12/2025, 05:12:15
- Last update
- 23/09/2026, 02:35:21
Track Medartis Holding AG with an AI analyst
See which prediction-market events move MDRSF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.